Chemours Historical Cash Flow

CC Stock  USD 14.15  0.30  2.08%   
Analysis of Chemours cash flow over time is an excellent tool to project Chemours future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 17.9 M or Depreciation of 315.1 M as it is a great indicator of Chemours ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Chemours latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chemours is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About Chemours Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Chemours balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Chemours's non-liquid assets can be easily converted into cash.

Chemours Cash Flow Chart

At present, Chemours' Other Cashflows From Financing Activities is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 315.1 M, whereas Change To Inventory is projected to grow to (138.7 M).

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Capital Expenditures

Capital Expenditures are funds used by Chemours to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Chemours operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most accounts from Chemours' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
At present, Chemours' Other Cashflows From Financing Activities is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 315.1 M, whereas Change To Inventory is projected to grow to (138.7 M).
 2022 2023 2024 2025 (projected)
Begin Period Cash Flow1.6B1.3B1.8B1.3B
End Period Cash Flow1.3B1.8B763M1.3B

Chemours cash flow statement Correlations

0.06-0.240.540.190.610.150.09-0.690.470.280.22-0.080.03-0.010.32-0.220.09-0.07-0.28-0.27
0.06-0.390.070.490.08-0.11-0.28-0.53-0.43-0.16-0.16-0.740.090.490.13-0.01-0.230.760.590.29
-0.24-0.390.5-0.29-0.26-0.130.160.74-0.220.520.610.32-0.16-0.32-0.350.150.33-0.16-0.42-0.48
0.540.070.50.00.150.010.08-0.2-0.010.660.690.01-0.150.01-0.02-0.180.180.09-0.35-0.29
0.190.49-0.290.00.04-0.62-0.12-0.45-0.25-0.21-0.45-0.80.110.580.53-0.48-0.530.690.690.41
0.610.08-0.260.150.040.40.36-0.460.090.2-0.08-0.070.59-0.290.38-0.05-0.1-0.18-0.11-0.29
0.15-0.11-0.130.01-0.620.40.23-0.050.010.030.110.480.47-0.58-0.120.240.03-0.44-0.29-0.34
0.09-0.280.160.08-0.120.360.230.07-0.290.2-0.290.070.43-0.420.62-0.23-0.47-0.280.050.03
-0.69-0.530.74-0.2-0.45-0.46-0.050.07-0.190.110.230.45-0.15-0.37-0.480.330.31-0.33-0.3-0.35
0.47-0.43-0.22-0.01-0.250.090.01-0.29-0.19-0.070.30.52-0.36-0.08-0.270.160.57-0.47-0.62-0.2
0.28-0.160.520.66-0.210.20.030.20.11-0.070.420.15-0.320.08-0.13-0.380.28-0.34-0.5-0.5
0.22-0.160.610.69-0.45-0.080.11-0.290.230.30.420.41-0.35-0.24-0.610.450.76-0.1-0.71-0.51
-0.08-0.740.320.01-0.8-0.070.480.070.450.520.150.41-0.04-0.59-0.520.290.5-0.84-0.78-0.43
0.030.09-0.16-0.150.110.590.470.43-0.15-0.36-0.32-0.35-0.04-0.530.450.09-0.530.020.330.02
-0.010.49-0.320.010.58-0.29-0.58-0.42-0.37-0.080.08-0.24-0.59-0.53-0.01-0.58-0.170.50.420.53
0.320.13-0.35-0.020.530.38-0.120.62-0.48-0.27-0.13-0.61-0.520.45-0.01-0.43-0.780.240.550.34
-0.22-0.010.15-0.18-0.48-0.050.24-0.230.330.16-0.380.450.290.09-0.58-0.430.560.01-0.3-0.32
0.09-0.230.330.18-0.53-0.10.03-0.470.310.570.280.760.5-0.53-0.17-0.780.56-0.34-0.8-0.59
-0.070.76-0.160.090.69-0.18-0.44-0.28-0.33-0.47-0.34-0.1-0.840.020.50.240.01-0.340.680.49
-0.280.59-0.42-0.350.69-0.11-0.290.05-0.3-0.62-0.5-0.71-0.780.330.420.55-0.3-0.80.680.67
-0.270.29-0.48-0.290.41-0.29-0.340.03-0.35-0.2-0.5-0.51-0.430.020.530.34-0.32-0.590.490.67
Click cells to compare fundamentals

Chemours Account Relationship Matchups

Chemours cash flow statement Accounts

202020212022202320242025 (projected)
Change To Inventory126M(202M)(390M)58M(146M)(138.7M)
Free Cash Flow540M543M447M186M(993M)(943.4M)
Change In Working Capital356M27M(104M)620M(1.1B)(999.4M)
Other Cashflows From Financing Activities1.1B(32M)43M(3M)17M17.9M
Depreciation320M317M291M307M301M315.2M
Other Non Cash Items399M16M(89M)(58M)44M51.1M
Capital Expenditures267M277M307M370M360M323.3M
Total Cash From Operating Activities807M820M754M556M(633M)(601.4M)
Change To Account Receivables12M(225M)91M(10M)(9M)(8.6M)
Net Income219M608M578M(238M)86M81.7M
Total Cash From Financing Activities(449M)(560M)(685M)172M(36M)(37.8M)
Other Cashflows From Investing Activities6M497M20M141M7M6.7M
Sale Purchase Of Stock(322M)12M(173M)(495M)(69M)0.0
Investments27M(12M)3M(229M)(353M)(335.4M)
Change In Cash162M446M(247M)503M(1.0B)(991.8M)
Net Borrowings128M(136M)(29M)(1M)(900K)(855K)
Total Cashflows From Investing Activities(483M)(234M)220M(284M)(326.6M)(342.9M)
Change To Netincome263M(76M)(124M)(10M)(11.5M)(12.1M)
Change To Liabilities(169M)55M454M195M224.3M235.5M
Change Receivables191M175M(225M)91M104.7M109.9M
Cash And Cash Equivalents Changes(252M)124M480M(215M)(193.5M)(183.8M)
End Period Cash Flow1.1B1.6B1.3B1.8B763M1.3B
Begin Period Cash Flow943M1.1B1.6B1.3B1.8B1.3B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.65)
Dividend Share
1
Earnings Share
0.57
Revenue Per Share
38.677
Quarterly Revenue Growth
(0.01)
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.